Invesaro

Stocks SURG Financial statements

Financial statements

SurgePays, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SurgePays, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue3.313.515.225.754.451.112213760.957
Cost of revenue2.338.18.5722.651.944.910810175.267.6
Gross profit0.975.366.673.122.476.1713.535.6-14.3-10.6
Selling, general and administrative3.275.158.0610.712.612.212.816.827.520.1
Selling and marketing0.150.110.27
Operating expenses12.612.212.816.827.520.1
Operating income-3.110.2-1.54-7.77-10.1-5.990.6318.9-43.5-34.1
Interest expense0.40.552
Interest income0.110.06
Other non-operating income-1.492.560.08-0.68-0.58-7.54-1.19-0.490.4-1.93
Pre-tax income-4.62.77-1.46-8.45-10.7-0.5518.4-43.1-36.1
Income tax0.08-2.272.87
Net income to minority interests0.130.03-0.21-0
Net income-4.62.77-1.54-8.45-10.7-13.5-0.6820.6-45.7-36.1
EBITDA-2.670.21-1.39-7.54-8.97-5.231.5719.8-42.5-33.9
EPS, basic-5.022.01-1.00-4.52-5.02-3.09-0.051.45-2.39-1.80
EPS, diluted-5.022.01-1.00-4.52-5.02-3.09-0.051.38-2.39-1.80
Shares, basic (weighted)0.891.521.621.922.134.3812.414.319.120.1
Shares, diluted (weighted)0.891.521.621.922.134.3812.414.919.120.1

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents0.441.270.440.350.676.287.0414.611.81.73
Receivables0.130.010.213.060.183.259.239.5434.05
Inventory0.184.3611.29.051.780.34
Other current assets0.570.050.010.10.010.110.160.30.58
Total current assets0.762.993.063.571.2513.927.633.417.96.98
Property, plant and equipment0.010.030.030.290.240.20.640.360.590.4
Lease right-of-use assets0.210.370.490.430.390.560.31
Goodwill0.870.870.870.870.870.871.671.673.3
Intangible assets0.220.10.074.774.133.432.782.131.470.82
Other non-current assets0.060.070.06
Total assets2.363.084.089.997.3319.53441.9248.52
Accounts payable0.780.333.13.646.836.65.78
Deferred revenue0.170.130.050.280.240.02
Short-term debt1.790.440.580.7417
Total current liabilities4.062.814.797.0515.71023.512.76.0618.2
Long-term debt0.060.050.682.211.1214.49
Lease liabilities0.120.160.440.40.360.320.1
Total liabilities4.173.696.0714.718.115.928.913.58.7123.9
Total debt1.850.491.268.527.827.675.054.0315.2
Paid-in capital4.15-0.160.336.0610.938.740.843.476.883.2
Retained earnings-6.03-0.62-2.42-10.9-21.6-35.1-35.8-15.2-60.9-97
Treasury stock-1.07-0.63-1.63
Shareholders' equity-3.38-0.62-1.99-4.7-10.73.554.9928.215.3-15.3
Minority interests0.130.15-0.05-0.06
Total equity-3.38-0.62-1.99-4.7-10.73.555.1228.415.3-15.4
Total liabilities and equity2.363.084.089.997.3319.53441.9248.52
Shares outstanding1.143.041.752.042.5412.114.114.420.121.2

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-4.6-1.98-1.54-8.45-10.7-13.5-0.5520.6-45.9-36.1
Depreciation and amortization0.430.010.150.231.170.760.930.940.940.21
Stock-based compensation0.160.330.1800.040.611.611.7
Change in receivables0.110-0.1-3.61.15-3.09-5.92-0.46.54-1.04
Change in inventory-0.18-4.26-6.882.147.271.44
Change in payables0.43-2.80.931.472.824.06-0.81
Cash from operations-0.640.23-1.02-6.53-4.33-15.30.7910.3-21.3-21.3
Capital expenditures-0-0.15-0.33-0.23-0.01-0.05-0.01-0.52-0.02
Acquisitions-0.8-2.5
Purchases of investments-10.2
Cash from investing-0.5-0.15-0.28-0.030.01-0.38-1.5-0.28-3-0.02
Debt repaid-0.53-0.34-0.67-0.01-0.01-0.01-0.01
Stock issued17.21.77
Share buybacks-0.5
Cash from financing1.140.610.466.474.6521.31.46-2.4222.510.5
Net change in cash-0.010.83-0.83-0.10.335.610.757.59-1.83-10.8
Free cash flow-0.640.08-1.35-6.76-4.33-15.30.78-21.8-21.3
Interest paid0.0300.010.080.10.870.520.220.470.25
Income taxes paid0.08

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.15 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin-19.6%Gross profit / revenue.
Operating margin-41.0%Operating income / revenue.
EBITDA margin-40.8%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-47.9%Pre-tax income / revenue.
Net margin-47.9%Net income / revenue.
Operating cash flow margin-23.0%Cash from operations / revenue.
Return on assets (ROA)-347.6%Net income / average total assets.
SG&A / revenue29.0%Selling, general and administrative expense / revenue.
D&A / revenue0.2%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-6.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-22.3%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y0.9%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-200.2%Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y-64.5%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-37.0%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y3.1%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y5.1%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y17.5%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y56.6%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.19xCurrent assets / current liabilities.
Quick ratio0.14x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.07x(Cash + short-term investments) / current liabilities.
Debt / assets191.5%Total debt / total assets.
Liabilities / assets324.6%Total liabilities / total assets.
Net debt$15.7MTotal debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage-7.68xOperating income / interest expense.
Working capital-$21.3MCurrent assets - current liabilities.
Goodwill and intangibles / assets5.3%(Goodwill + intangible assets) / total assets.
Tangible book value-$21.2MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover7.26xRevenue / average total assets.
Fixed asset turnover192xRevenue / average property, plant and equipment.
Inventory turnover316xCost of revenue / average inventory.
Days inventory1 days365 x average inventory / cost of revenue.
Receivables turnover36.7xRevenue / average receivables.
Days sales outstanding10 days365 x average receivables / revenue.

Per share

MetricValueHow it is calculated
EPS, diluted-$1.24Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$2.59Revenue / diluted weighted shares.
Operating cash flow per share-$0.59Cash from operations / diluted weighted shares.
Book value per share-$0.78Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$0.80Tangible book value / shares outstanding.
Cash per share$0.07(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$3.7MShare price x shares outstanding.
Enterprise value$19.4MMarket cap + total debt - cash - short-term investments.
P/S0.05xMarket cap / revenue.
EV/Sales0.29xEnterprise value / revenue.
Earnings yield-873.2%Net income / market cap (the inverse of P/E).
What was SurgePays, Inc.'s revenue in fiscal 2025?

SurgePays, Inc. reported revenue of $57.0M for fiscal 2025, 6.4% lower than the year before.

Was SurgePays, Inc. profitable in fiscal 2025?

No. It reported a net loss of $36.1M.

How much free cash flow did SurgePays, Inc. generate in fiscal 2025?

Cash from operations of $21.3M minus capital expenditures of $18.6K left free cash flow of -$21.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SurgePays, Inc.